Evidence map›Paper›PMID 27815799›Full record

Trial reportLipids2016

CLA Has a Useful Effect on Bone Markers in Patients with Rheumatoid Arthritis.

N Aryaeian, F Shahram, M Djalali

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Lipids, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Review
  3. Conjugated Linoleic Acid in Cancer Therapy.Current drug delivery · 2025
    Review
  4. Article
  5. Molecular Interactions between Dietary Lipids and Bone Tissue during Aging.International journal of molecular sciences · 2021
    Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

N AryaeianResearch Center for Environmental Health Technology, Iran University of Medical Sciences and Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.
F ShahramRheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
M DjalaliDepartments of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran. jalalimahmoud@hotmail.com.
Tehran University of Medical Sciences · IRIran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rheumatoid arthritis is a systemic, chronic disease which may increase the risk of osteoporosis. This study was carried out in order to examine the effect of conjugated linoleic acid (CLA) on bone markers in rheumatoid arthritis disease which is the most common autoimmune disease. The present study is a randomized double-blind clinical trial. Subjects included 52 patients with active rheumatoid arthritis who were divided into two groups. Group I received standard treatment plus 2 daily 1.25 g capsules (Containing about 2 g of 9-cis 11-trans isomer and 10-cis 12-trans isomer in ratio of 50 -50 CLA in glycerinated form), Group II received standard treatment plus 2 Placebo 1.25 g capsules containing sunflower oil with high oleic acid. Telopeptides C, osteocalcin, and MMP3 were analyzed by ELISA method, PGE

findingsThere was no significant difference between the groups in enzyme activity of ALK-P of bone, PGE

Indexed as

AdultAgedArthritis, RheumatoidBiomarkersBone and BonesDinoprostoneDouble-Blind MethodFemaleGene Expression RegulationHumansInsulin-Like Growth Factor ILinoleic Acids, ConjugatedMaleMatrix Metalloproteinase 3Middle AgedOsteocalcinBiomarkersDinoprostoneIGF1 protein, humanInsulin-Like Growth Factor ILinoleic Acids, ConjugatedMatrix Metalloproteinase 3MMP3 protein, humanOsteocalcinBone ALK-PCLAOsteocalcinRheumatoid arthritisTelopeptide C

Identifiers

PMID27815799
OpenAlexW2548561237

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.